RECOMBINANT TECHNOLOGIES

recombinant-technologies-logo

Recombinant Technologies is an emerging biotechnology company.

#SimilarOrganizations #People #Website #More

RECOMBINANT TECHNOLOGIES

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
1999-01-01

Address:
Cheshire, Connecticut, United States

Country:
United States

Website Url:
http://www.recombtech.com

Total Employee:
1+

Status:
Active

Contact:
(203) 271-3125

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Apache Global Site Tag Google Maps YouTube Google Maps API


Similar Organizations

antimicrobial-materials-logo

Antimicrobial Materials

Antimicrobial Materials is an emerging technology company.

future-genomics-technologies-logo

Future Genomics Technologies

Future Genomics Technologies is a cutting edge genomics technology company.

genia-technologies-logo

Genia Technologies

Genia Technologies is a biotechnology company.

pathens-logo

Pathens

Pathens Incorporated is an emerging biotechnology company.

Current Employees Featured

pazhani-sundaram_image

Pazhani Sundaram
Pazhani Sundaram Founder-President and CEO @ Recombinant Technologies
Founder-President and CEO
1998-05-01

Founder


pazhani-sundaram_image

Pazhani Sundaram

Official Site Inspections

http://www.recombtech.com

  • Host name: 74-208-236-202.elastic-ssl.ui-r.com
  • IP address: 74.208.236.202
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Recombinant Technologies"

Board of Directors - Recombtech

Dr. Sundram has strong experience in protein expression technologies, molecular biology, biochemistry, peptidomimetics and in drug delivery systems. Prior to starting Recombinant โ€ฆSee details»

Recombtech

Sep 27, 2021ย ยท Our mission is to effectively alleviate beta-amyloidopathy symptoms without subjecting patients to pain and suffering. Our passion is to improve the quality of life in patients โ€ฆSee details»

Leadership - Recombtech

With more than 30 years in industry, most devoted to medical devices, Kennel has hands-on experience with development and manufacturing as well as Regulatory Affairs (RA)/Quality Assurance (QA) and clinical roles in both โ€ฆSee details»

Pazhani Sundaram - President, Principal Investigator, and Chief ...

He is the founder of Recombinant Technologies, a pre-clinical stage biotechnology company [www.recombtech.com]. Dr. Sundaram has strong experience in protein expression โ€ฆSee details»

Recombinant Technologies - highergov.com

The organization was founded in May 1998 and federally registered in September 2005.See details»

Recombinant Technologies LLC - SignalHire

Organization Website: recombtech.com : Recombinant Technolo... industries Biotech: Headquarters Location: 1090 Meriden Waterbury Road, Cheshire, Connecticut, 06410 US โ€ฆSee details»

RECOMBINANT TECHNOLOGIES, LLC | VentureRadar

Website: http://www.RECOMBTECH.COM/ Develops therapeutics for neurodegenerative diseases using patented molecule AmyTrap, which captures and clears beta-amyloid peptide, โ€ฆSee details»

Recombinant Technologies - Overview, News & Similar

Jul 22, 2021ย ยท View Recombinant Technologies (www.recombtech.com) location in Connecticut, United States , revenue, industry and description. Find related and similar companies as well โ€ฆSee details»

Contact - Recombtech

Have anything to say or any quires?, Feel free to contact us. We're here to help you. If you really want to make a difference - make it with us. Recombtech, Amytrap, AmyTrap in Action, Cure โ€ฆSee details»

Better Living for People With Alzheimer's: One of a Kind

The following video best illustrates the Amytrapper device https://www.recombtech.com/#. These proposed innovative devices trap amyloid from circulation (just like dialysis to remove urea...See details»

Recombinant Technologies, Inc. - embarc.com

As of 2022-01-11, raising $10,000.00-$1,070,000.00 via 10,000+ of Common Stock at $1.00 by 2022-02-11 Costing 7% in cash and 2% in equitySee details»

Recombinant Technologies - Crunchbase Company Profile

Recombinant Technologies is an emerging biotechnology company. There is no recent news or activity for this profile. Where is Recombinant Technologies's headquarters? Recombinant โ€ฆSee details»

Recombinant Technologies | Cheshire CT - Facebook

Recombinant Technologies, Cheshire, Connecticut. 51 likes. Recombinant Technologies, LLC, is an emerging biotechnology company focused on developing...See details»

Recombinant Technologies is Raising Capital to Roll Out a Game โ€ฆ

CHESHIRE, Conn., Sept. 27, 2021 /PRNewswire/ โ€” Ask anyone who spent time with a close friend or family member with Alzheimerโ€™s Disease and theyโ€™ll tell you they wouldnโ€™t wish it on โ€ฆSee details»

RECOMBINANT TECHNOLOGIES, LLC - VentureRadar

Website: http://www.RECOMBTECH.COM/ Develops therapeutics for neurodegenerative diseases using patented molecule AmyTrap, which captures and clears beta-amyloid peptide, โ€ฆSee details»

Recombinant Technologies is Raising Capital to Roll Out a Game โ€ฆ

Sep 27, 2021ย ยท Recombinant Technologies has received multiple peer-reviewed grants (which in itself is a stamp of approval) from the National Institutes of Health to develop this Amytrapper โ€ฆSee details»

Welcome to Recombinant Technologies

Recombinant Technologies has developed a unique treatment to a devastating medical problem to alleviate the anguish and bring relief. It is estimated that nearly 6 million people suffer from โ€ฆSee details»

Current Pipeline - Recombtech

Recombinant Technologies, LLC 1090, Meriden Waterbury Road, Suite1 06410, USA. Tel: + (203)271-3125(T), Fax: + (203)271-3126 E-mail: [email protected]See details»

Recombinant C/A Crowdfunding $10K to $1.07M in Common Stock

Crowdfunding $10K to $1.07M in Common Stock, C/A SEC filing by Recombinant on 11 Jan 22, 4:27pmSee details»

Welcome to Recombinant Technologies - recombtech.com

CII has awarded a bridge grant that is supporting the current efforts to improve the value of the small molecule therapeutic. CII has shown interest to continue to support future โ€ฆSee details»

linkstock.net © 2022. All rights reserved